Synaptic degeneration in Alzheimer disease

M Tzioras, RI McGeachan, CS Durrant… - Nature Reviews …, 2023 - nature.com
Alzheimer disease (AD) is characterized by progressive cognitive decline in older
individuals accompanied by the presence of two pathological protein aggregates—amyloid …

Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer's disease

C Sharma, S Kim, Y Nam, UJ Jung, SR Kim - International Journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is the most frequent cause of age-related neurodegeneration and
cognitive impairment, and there are currently no broadly effective therapies. The underlying …

[HTML][HTML] Synapse pathology in Alzheimer's disease

J Griffiths, SGN Grant - Seminars in Cell & Developmental Biology, 2023 - Elsevier
Synapse loss and damage are central features of Alzheimer's disease (AD) and contribute to
the onset and progression of its behavioural and physiological features. Here we review the …

Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease

JS Bhatti, S Kaur, J Mishra, H Dibbanti, A Singh… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disease that manifests its pathology
through synaptic damage, mitochondrial abnormalities, microRNA deregulation, hormonal …

Mitochondrial dysfunction and neurological disorders: a narrative review and treatment overview

EE Alshial, MI Abdulghaney, AHS Wadan… - Life Sciences, 2023 - Elsevier
Mitochondria play a vital role in the nervous system, as they are responsible for generating
energy in the form of ATP and regulating cellular processes such as calcium (Ca 2+) …

Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model

W Chen, Q Huang, EK Lazdon… - Proceedings of the …, 2023 - National Acad Sciences
Brain insulin signaling controls peripheral energy metabolism and plays a key role in the
regulation of mood and cognition. Epidemiological studies have indicated a strong …

A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: statistical approach vs machine learning approach

MS Tan, PL Cheah, AV Chin, LM Looi… - Computers in biology and …, 2021 - Elsevier
Alzheimer's Disease (AD) is a neurodegenerative disease that affects cognition and is the
most common cause of dementia in the elderly. As the number of elderly individuals …

Neurobiological highlights of cognitive impairment in psychiatric disorders

A Morozova, Y Zorkina, O Abramova… - International Journal of …, 2022 - mdpi.com
This review is focused on several psychiatric disorders in which cognitive impairment is a
major component of the disease, influencing life quality. There are plenty of data proving that …

[HTML][HTML] Mitochondrial dysfunction in Alzheimer's disease: opportunities for drug development

S Bhatia, R Rawal, P Sharma, T Singh… - Current …, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is one of the major reasons for 60-80% cases of senile dementia
occurring as a result of the accumulation of plaques and tangles in the hippocampal and …

Dysfunction of mitochondria in Alzheimer's disease: ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells

A Atlante, D Valenti, V Latina, G Amadoro - International journal of …, 2022 - mdpi.com
Alzheimer's disease (AD), certainly the most widespread proteinopathy, has as classical
neuropathological hallmarks, two groups of protein aggregates: senile plaques and …